Trade Agreement: Agreement on Internal Trade (AIT)
Tendering Procedures:
Attachment: None
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
GlaxoSmithKline Inc.
7333 Mississauga Road North
Mississauga Ontario
Canada
L5N6L4
Nature of Requirements:
Definition of requirement
This requirement is to provide Hepatitis "A" & "B" vaccines
(recombinant) in the quantities estimated for use by various
Federal, Provincial and Territorial (FPT) Government Department
Designated Users under the FPT Group Purchasing Program.
Each consignee will be obligated to purchase only 90% of their
estimated requirement.
Any resulting contract will include an option to add new users
and to increase the quantity required for any given item by up
to 20% of the total estimated requirement to accommodate the
increased requirements of existing users.
Item descriptions are as follow:
Item 1 : Hepatitis A & B combined vaccine, adult, single dose
1.0ml pre-filled syringue.
Item 2 : Hepatitis A and B combined Vaccine, Pediatric Single
dose 0.5 ml pre-filled syringe.
Period of proposed contract
Contract period to be from April 1, 2013 to March 31, 2014, with
an option to extend the contract period for two additional
one-year periods from April 1, 2014 to March 31, 2015 and from
April 1, 2015 to March 31, 2016.
Quantities
Item 1: 10,105 doses
Item 2: 1,016 doses
Delivery
Will be on an as-and-when requested basis.
Trade Agreement
The provisions of the WTO-AGP, NAFTA, Canada-Chile Free Trade
Agreement (CCFTA) and Canada-Columbia Free Trade Agreement
(CCOFTA) and Canada- Peru Free Trade Agreement (CPFTA) are not
applicable for reasons connected with the protection of human
life and health (see NAFTA article 1018 para. 2 (a) and (b);
WTO-AGP article XXIII (2); CCFTA article Kbis-16 para. 2 (b);
CCOFTA article 2201 para 3 (a); and CPFTA article 1402 para. 2
(b) ), and because of the absence of regulatory harmonization
between Canada and the other signatory countries to the WTO,
NAFTA, CCOPTA; CCFTA and CPFTA. This requirement is subject to
the Agreement on Internal Trade (AIT).
Canada and PWGSC as Agent
This requirement is for the Federal/Provincial/Territorial
(F/P/T) Group Purchasing Program for Drugs and Vaccines. Canada
is acting as a purchasing agent for Provincial and/or
Territorial Governments.
Limited Tendering Reason
It is intended to negotiate directly with GlaxoSmithKline Inc.,
as they are the only known source of supply licensed by Health
Canada's Biologics and Genetic Therapies Directorate (BGTD) to
supply in Canada (licensed under the registered trademark
Twinrix®).
Delivery Date: 31/03/2014
You are hereby notified that the government intends to negotiate
with one firm only as identified above. Should you have any
questions concerning this requirement, contact the contracting
officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and
agencies to post a notice, for no less than fifteen (15)
calendar days, indicating to the supplier community that it
intends to award a good, service or construction contract to a
pre-identified contractor. If no other supplier submits, on or
before the closing date, a Statement of Capabilities that meets
the requirements set out in the ACAN, the contracting authority
may then proceed with the award. However, should a Statement of
Capabilities be found to meet the requirements set out in the
ACAN, then the contracting authority will proceed to a full
tendering process.
Suppliers who consider themselves fully qualified and available
to provide the services/goods described herein, may submit a
statement of capabilities in writing to the contact person
identified in this Notice on or before the closing date of this
Notice. The statement of capabilities must clearly demonstrate
how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the
closing date of the ACAN must appear on the outside of the
envelope in block letters or, in the case of a facsimile
transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any
procurement.
Documents may be submitted in either official language of Canada.
